Ranging from manageable to severe, millions of people suffer from neurological disorders and diseases globally. Discover how five innovative startups are enabling faster diagnosis of brain disease to try and save hundreds of thousands of lives annually.
Out of 560, the Global Startup Heat Map highlights 5 Top Brain Disease Diagnosis Startups
Startups such as the examples highlighted in this report focus on rapid autism spectrum disorders diagnosis, stroke diagnosis, early-stage Alzheimer’s detection, and non-convulsive seizure screening. While all of these technologies play a significant role in advancing healthcare, they only represent the tip of the iceberg. This time, you get to discover five hand-picked brain disease diagnosis startups.
The Global Startup Heat Map below reveals the geographical distribution of 560 exemplary startups & scaleups we analyzed for this research. Further, it highlights five healthcare startups that we hand-picked based on scouting criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 555 brain disease diagnosis startups, get in touch with us.
VISUAL
BioROSA Technologies offers Rapid Autism Spectrum Disorders (ASD) Diagnosis
Founding Year: 2018
Location: Boston, USA
Partner with BioROSA Technologies for Autism Blood Test
US-based startup BioROSA Technologies provides a rapid diagnosis of autism spectrum disorders (ASD). Its blood test solution, BioROSA, measures biomarkers. Whereas, its proprietary machine learning algorithms analyze this data to predict ASD. The startup’s technology finds use in therapeutic trials to assess pharmacodynamics, patient stratification, and companion diagnostics. This provides doctors with the tools to enable early disease detection and diagnosis as well as ensure timely treatment.
AgenT provides Early-Stage Alzheimer’s Detection
Founding Year: 2018
Location: Paris, France
Funding: USD 491 000
Partner with AgenT for Blood Plasma Analysis
French startup AgenT offers a diagnostic test to detect Alzheimer’s in the early stage. The startup’s blood test combines machine learning and multi-omics biomarkers signals of Alzheimer’s. It analyzes proteins and metabolites in the blood plasma to stratify the Alzheimer’s disease progression into 3 stages. Thus, AgenT enables clinicians to deliver personalized care.
Head Diagnostics develops a Non-Invasive Brain Diagnostic Device
Founding Year: 2018
Location: Dublin, Ireland
Partner with Head Diagnostics for Concussion Diagnostics
Irish startup Head Diagnostics makes a handheld medical device for the diagnosis of concussion (mTBI) and Parkinson’s Disease (PD). It provides rapid assessment to assist clinicians in making an objective diagnosis of brain diseases and brain impairment. This way, Head Diagnostics advances the diagnosis of brain disorders with its non-invasive test eliminating the need for computerized tomography (CT) scans.
Cerebra advances Stroke Diagnosis
Founding Year: 2020
Location: Almaty, Kazakhstan
Funding: USD 1,3 M
Partner with Cerebra for Automated Brain Disease Diagnosis
Kazakhstani startup Cerebra builds an AI-powered platform for stroke detection. Conventional diagnostics methods like CT scans do not detect cytotoxic edema, limiting early stroke recognition. The startup’s platform detects stroke under 10 minutes and within the therapeutic window to provide appropriate and early care. It also calculates the change in tissue density in the core of the stroke and also compares it with the rest of the unaffected brain parenchyma. Hence, Cerebra enables automated diagnosis of ischemic and hemorrhagic strokes.
CenSyn enables Non-convulsive Seizure Screening
Founding Year: 2019
Location: Irvine, USA
Partner with CenSyn offers for Remote Tele-Neurology Monitoring
US-based startup CenSyn develops an electroencephalogram (EEG)-based device to screen for non-convulsive seizures in neuro-ICU patients. The startup’s hand-held device, PenEEG, features in-built machine learning algorithms to detect the presence of altered mental status. CenSyn’s platform, CenSyn Scope, wirelessly displays the EEG data and also provides tests to determine cognitive performance, including SCAT-5 and n-Back. CenSyn, thus, aids in auto EEG signal detection and provides out-of-hospital EEG reviews for patients.
Where is this Data from & how to Discover More Healthcare Startups?
The insights of this data-driven analysis are derived from our Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & lets you scout relevant startups within a specific field in just a few clicks. To explore healthcare technologies in more detail, let us look into your areas of interest.
Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. For a more general overview, download our free Healthcare Innovation Report to save your time and improve strategic decision-making.
